Vosoritide beneficial for children younger than 5 years with achondroplasia
by Elana GotkineFor children with achondroplasia, vosoritide is associated with a gain in the change in height Z score from baseline and a mild adverse event profile, according to a study published in
Updated on: January 26,2024
17

Vosoritide beneficial for children younger than 5 years with achondroplasia
by Elana GotkineFor children with achondroplasia, vosoritide is associated with a gain in the change in height Z score from baseline and a mild adverse event profile, according to a study published in
Updated on:January 26,2024
17
